// App-Quantinova.ai

937 : L-Asparaginase Allergic Patients Treated with L-Asparaginase Loaded into Red Blood Cells in an Expanded Access Program. Report of Four Cases

Researchers

Presenter

  • Audrey Contet

Principal Investigators

  • Severine Lissandre

  • Celine Berthon

  • Yann Godfrin

  • Yves Bertrand

Medical Centers

  • Onco-Hematology, CHU Nancy-Brabois, Vandoeuvre les Nancy, France

  • CHRU de Tours, Tours, France

  • Pediatric Hematology Department, IHOP and Claude Bernard University, Lyon, France

  • Service des Maladies du Sang, Centre hospitalo-universitaire Lille, Lille, France

Locations

  • France

Companies

  • Erytech Pharma Inc.

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Acute lymphoblastic leukemia

  • Anaphylaxis

  • B-cell acute lymphoblastic leukemia

  • T-cell acute lymphoblastic leukemia

  • Acute lung injury

Biomarkers

  • Breakpoint Cluster Region

  • Red Blood Cells

Drug/Treatment

  • Hydrocortisone

  • Asparaginase

  • Prednisone

  • histamine

  • Erwinase

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved